According to statistics, on average, one out of 17 women worldwide develops BC in their whole life, and the majority of the patients with breast malignant tumor are the ones with hormone receptor-positive breast cancer, which account for about 65% [6]. This evidence concerns the gene NR4A1 and breast cancer.